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INTRODUCTION 
 
The normal thyroid gland is impalpable. The term goiter (Latin, 
guttur = the throat) is used to describe generalised enlargement of 
the thyroid gland. It is a ductless gland. 
                  Biosynthetic defects, iodine deficiency, autoimmune 
disease, and nodular diseases can each lead to goiter, though by 
different mechanisms. Graves' disease and Hashimoto's thyroiditis 
are also associated with goiter. In addition various forms of thyroid 
cancer are relatively common and amenable to detection by 
physical examination. 
                 Unique features of thyroid cancer are (1) thyroid 
nodules are readily palpable, allowing early detection and biopsy 
by FNA; (2) iodine radioisotopes can be used to diagnose (123I) 
and treat (131I) differentiated thyroid cancer, reflecting the unique 
uptake of this anion by the thyroid gland; and (3) serum markers 
allow the detection of residual or recurrent disease, including the 
use of Tg levels for PTC and FTC and calcitonin for medullary 
thyroid cancer (MTC). Differentiated tumors, such as papillary 
thyroid cancer (PTC) or follicular thyroid cancer (FTC), are often 
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curable, and the prognosis is good for patients identified with early-
stage disease. 
                       Because the management of goiter depends on the 
etiology, the detection of thyroid enlargement on physical 
examination should prompt further evaluation to identify its cause. 
                        More sensitive methods of detection, such as CT, 
thyroid ultrasound, and pathologic studies, reveal thyroid nodules 
in >20% of glands. Most authorities still rely on physical 
examination to detect thyroid nodules, reserving ultrasound for 
monitoring nodule size or as an aid in thyroid biopsy. 
                          Otherwise, FNA biopsy should be the first step in 
the evaluation of a thyroid nodule. FNA has good sensitivity and 
specificity .The technique is particularly good for detecting PTC. 
The distinction of benign and malignant follicular lesions is often 
not possible using cytology alone. 
                 In this study, much emphasis is placed on the clinical 
presentation of thyroid swellings and the role of pathological 
investigations in the management of thyroid swellings.
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AIM OF THE STUDY 
 
                  Treatment modalities of thyroid swellings depend on 
the clinical presentation and pathological evaluation of thyroid 
swellings. 
The aim of the study is to analyze the clinical presentation of 
thyroid swellings and the role of FNAC in the diagnosis and 
surgery for thyroid swellings over a period extending from July 
2007 to October 2009. 
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Historical Background 
Goiters have been recognized since 2700 B.C. In 1619, 
Hieronymus Fabricius ab Aquapendente recognized that goiters 
arose from the thyroid gland. The term thyroid gland (Greek 
thyreoeides, shield-shaped) is, however, attributed to Thomas 
Wharton in his Adenographia (1656). In 1776, the thyroid was 
classified as a ductless gland by Albrecht von Haller 
 Roger Frugardi in 1170. In response to failure of medical 
treatment, two setons were inserted at right angles into the goiter 
and tightened twice daily until the goiter separated. 
The most notable thyroid surgeons were Emil Theodor Kocher 
(1841–1917)  and C. A. Theodor Billroth (1829–1894) 
After total thyroidectomy, patients (particularly children) became 
myxedematous with cretinous features. Kocher used the term 
"cachexia strumipriva" to describe this condition 
Myxedema was first effectively treated in 1891 by George Murray, 
who used a subcutaneous injection of an extract of sheep's 
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thyroid; later, Edward Fox demonstrated that oral therapy was 
equally effective. 
In 1909, Kocher was awarded the Nobel Prize for medicine in 
recognition "for his works on the physiology, pathology, and 
surgery of the thyroid gland." 
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 EMBRYOLOGY 
The thyroid gland arises as an out pouching of the primitive foregut 
around the third week of gestation. It originates at the base of the 
tongue in the vicinity of the foramen cecum. Endoderm cells in the 
floor of the pharyngeal anlage thicken to form the medial thyroid 
anlage that descends in the neck anterior to structures that form 
the hyoid bone and larynx. It grows downward and backward as a 
tubular duct, which bifurcates and subsequently subdivides into a 
series of cellular cords, from which the isthmus and lateral lobes of 
the thyroid gland are developed. The ultimo-branchial bodies from 
the fifth pharyngeal pouches are enveloped by the lateral lobes of 
the thyroid gland; they undergo atrophy and do not form true 
thyroid tissue. The connection of the diverticulum with the pharynx 
is termed the thyroglossal duct; its continuity is subsequently 
interrupted, and it undergoes degeneration, its upper end being 
represented by the foramen cecum of the tongue, and its lower by 
the pyramidal lobe of the thyroid gland. The ultimobranchial bodies 
are neuroectodermal in origin and provide the calcitonin producing 
parafollicular or C cells, which come to lie in the superoposterior 
region of the gland. Microscopic thyroid follicles are first apparent 
as the lateral lobes develop. Thyroid follicles are initially apparent 
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by 8 weeks and colloid formation begins by the 11th week of 
gestation. In the 3rd month, the follicular cells first demonstrate 
iodine trapping, and thyroid hormone secretion initially begins. 
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Surgical anatomy 
General orientations 
The adult thyroid gland is brown in color and firm in consistency, 
and is located posterior to the strap (sternothyroid and 
sternohyoid) muscles. The thyroid gland is situated in the anterior 
triangle of the neck, weighs approximately 20 g, and consists of 
two lateral lobes (right and left), joined together by a midline 
isthmus. The small pyramidal lobe of Lalouette, of variable size, 
commonly joins the isthmus at its junction with the left lateral lobe 
by a fibrous band or strand of muscle fibers known as the levator 
glandulae thyroideae. The lobes measure approx. 5 × 3 × 1.5 cm 
(slightly larger in women) and extend from the middle of the thyroid 
cartilage above to the sixth tracheal ring below. Each lobe fills the 
space between the trachea and oesophagus medially and the 
carotid sheath laterally. The lateral or superficial surface is convex, 
and covered by the skin, the superficial and deep fascia, the 
Sternocleidomastoideus, the superior belly of the Omohyoideus, 
the Sternohyoideus and Sternothyreoideus, and beneath the last 
muscle by the pretracheal layer of the deep fascia, which forms a 
capsule for the gland. The deep or medial surface is moulded over 
the underlying structures, viz., the thyroid and cricoid cartilages, 
9 
 
the trachea, the Constrictor pharyngis inferior and posterior part of 
the Cricothyreoideus, the esophagus (particularly on the left side of 
the neck), the superior and inferior thyroid arteries, and the 
recurrent nerves. The anterior border is thin, and inclines obliquely 
from above downward toward the middle line of the neck, while the 
posterior border is thick and overlaps the common carotid artery, 
and, as a rule, the parathyroids. The isthmus (isthmus gl. 
thyreoidea) connects together the lower thirds of the lobes; it 
measures about 1.25 cm. in breadth, and the same in depth, and 
usually covers the second and third rings of the trachea. Its 
situation and size present, however, many variations. In the 
midline of the neck it is covered by the skin and fascia, and close 
to the midline, on either side, by the Sternothyreoideus. Across its 
upper border runs an anastomotic branch uniting the two superior 
thyroid arteries; at its lower border are the inferior thyroid veins. 
The thyroid gland is enveloped by a loosely connecting fascia that 
is formed from the partition of the deep cervical fascia into anterior 
and posterior divisions. The true capsule of the thyroid is a thin, 
densely adherent fibrous layer that sends out septa that invaginate 
into the gland, forming pseudolobules. The thyroid capsule is 
condensed into the posterior suspensory or Berry's ligament near 
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the cricoid cartilage and upper tracheal rings. The strap muscles 
(sternohyoid, sternothyroid and superior belly of the omohyoid) are 
located anteriorly and are innervated by the ansa cervicalis (ansa 
hypoglossi).  
Vascular supply to the thyroid. 
The arterial supply to the thyroid gland is supplied by four main 
arteries, two superior and two inferior. The superior thyroid artery 
is the first branch of the external carotid artery and separates from 
that structure immediately above the bifurcation of the common 
carotid artery. The superior thyroid artery then drops medially onto 
the surface of the inferior pharyngeal constrictor muscle and enters 
the substance of the superior pole of the thyroid at its apex. The 
superior thyroid artery courses medially with the external branch of 
the superior laryngeal nerve, and this structure must be separated 
from it when gaining control of the artery. At the apex of the lateral 
lobe, it divides into a large anterior branch and a usually smaller, 
but important, posterior branch. Occasionally a tributary leaves 
high on the left to supply the pyramidal lobe near the midline. 
                  The inferior thyroid artery takes its origin from the 
thyrocervical trunk. This artery ascends into the neck on either side 
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behind the carotid sheath and then arches medially and enters the 
thyroid gland posteriorly. There is no direct arterial supply to the 
thyroid at the inferior boundaries because most of these vascular 
structures are venous. An occasional inferior arterial supply may 
occur from a thyroidea ima artery that occurs in the absence of a 
well-defined inferior arterial supply. The thyroidea ima arteries 
occur in less than 5% of patients and usually arise directly from the 
innominate artery or from the aorta.  
The inferior thyroid artery has important anatomic relationships. 
The recurrent laryngeal nerve is usually directly adjacent (in either 
an anterior or posterior position) to the inferior thyroid artery within 
1 cm of its entrance into the larynx. Careful dissection of the artery 
in this case is mandatory and cannot be completed until 
knowledge of the position of the recurrent laryngeal nerve is 
gained. Additionally, the inferior thyroid artery almost always 
supplies both the superior and inferior parathyroid glands, and 
care must be taken in evaluating the parathyroids after inferior 
thyroid artery division. 
           Numerous unnamed accessory arteries arise from the 
oesophagus and trachea, but the most frequently encountered is 
the thyroidea ima (Neubauer's artery), which courses up anteriorly 
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on the trachea to reach the isthmus or one of the lower poles and 
originates from the aorta or brachiocephalic artery. In the absence 
of the inferior thyroid artery on one side, the thyroidea ima may be 
the principal source of blood supply to the lobe and therefore 
substantial. 
        Three pairs of venous systems drain the thyroid. Superior 
venous drainage is immediately adjacent to the superior arteries 
and joins the internal jugular vein at the level of the carotid 
bifurcation. The middle thyroid veins exist in more than half of 
patients and course immediately laterally into the internal jugular 
vein. The inferior thyroid veins are usually two or three in number 
and descend directly from the lower pole of the gland into the 
innominate and brachiocephalic veins. These veins often descend 
into the tail of the thymus gland. 
Lymphatic drainage 
The relationship of the thyroid gland to its lymphatic drainage is 
most important when considering surgical treatment of thyroid 
carcinoma. The thyroid gland and its neighboring structures have a 
rich lymphatic supply that drains the thyroid in almost every 
direction. Within the gland, lymphatic channels occur immediately 
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beneath the capsule and communicate between lobes through the 
isthmus. This drainage connects to structures immediately 
adjacent to the thyroid with numerous lymphatic channels into the 
regional lymph nodes. They drain primarily into mediastinal nodes 
inferiorly, tracheo-oesophageal nodes laterally, and the midline 
delphian nodes superiorly. Studies following injection of dye 
suggest that the majority of lymph from the thyroid returns to the 
thoracic duct without passing through the deep cervical lymph-
node chain or the nodes of the posterior triangle, although these 
pathways may open up secondarily. This has implications for the 
assessment of patients with carcinoma of the thyroid, who may 
develop lymph-node deposits outside the primary drainage areas, 
even on the contralateral side. 
Important anatomical relations 
Recurrent Laryngeal Nerve 
The recurrent laryngeal nerves ascend on either side of the 
trachea, and each lies just lateral to the ligament of Berry as it 
begins to enter the larynx. There are a number of important 
variations. In about 25% of patients, the recurrent laryngeal nerve 
is contained within the ligament as it enters the larynx. On the right 
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side, the recurrent laryngeal nerve separates from the vagus as it 
crosses the subclavian artery, passing posteriorly and ascending 
in a lateral position to the trachea along the tracheo-esophageal 
groove. The right recurrent laryngeal nerve can usually be found 
no further away than 1 cm lateral to or within the tracheo-
esophageal groove at the level of the lower border of the thyroid. 
As it ascends to the midportion of the thyroid, however, the nerve 
assumes its position within the tracheo-esophageal groove. At this 
location, the nerve might divide into one, two, or more branches as 
it enters into the first or second ring of the trachea, with the most 
important branch disappearing beneath the inferior border of the 
cricothyroid muscle. The nerve can usually be found immediately 
anterior or posterior to a main arterial trunk of the inferior thyroid 
artery at this level. Unusually, a nonrecurrent right laryngeal nerve 
can arise directly from the vagus and course directly medially into 
the larynx. This nonrecurrent anatomy is found in 0.5 to 1.5% of 
patients. Even more infrequently, patients may have both a 
recurrent and a nonrecurrent laryngeal nerve on the right. These 
two nerves usually join in a position beneath the lower border of 
the thyroid.  
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On the left side, the recurrent laryngeal nerve separates from the 
vagus as that nerve traverses over the arch of the aorta. The left 
recurrent laryngeal nerve then passes inferiorly and medially to the 
aorta and begins to ascend toward the larynx, finding its way into 
the tracheo-esophageal groove by the time it ascends to the level 
of the lower lobe of the thyroid. Both recurrent laryngeal nerves, by 
the time that they are within 2.5 cm of their entrance into the 
larynx, are consistently found within the tracheo-esophageal 
groove. These nerves pass either inferiorly or posteriorly to an 
arterial branch of the inferior thyroid artery and eventually enter the 
larynx at the level of the cricothyroid articulation on the caudal 
border of the cricothyroid muscle. Here the nerve is immediately 
adjacent to the superior parathyroid, the inferior thyroid artery, and 
the most posterior aspect of the thyroid. Great care is needed in 
surgical dissection in this area because the nerve is essentially 
tethered as it dives beneath the cricothyroid muscle and can be 
placed on stretch by over vigorous dissection .The motor function 
of the recurrent laryngeal nerve is abduction of the vocal cords 
from the midline. Damage to a recurrent laryngeal nerve results in 
paralysis of the vocal cord on the side affected. Such damage 
might result in a cord that remains in a medial position or just 
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lateral to the midline. A normal voice, albeit weakened, can occur if 
the remaining functioning contralateral cord is able to approximate 
the paralyzed cord. If the vocal cord remains paralyzed in an 
abducted position and closure cannot occur, a severely impaired 
voice and ineffective cough can be the result. If recurrent laryngeal 
nerves are damaged bilaterally, complete loss of voice or airway 
obstruction requiring emergency intubation and tracheostomy may 
be necessary. Occasionally, bilateral damage can result in cords 
taking an abducted position, which, although allowing airway 
movement, may result in upper respiratory infection due to 
ineffective cough.  
Superior Laryngeal Nerve 
The superior laryngeal nerve separates from the vagus nerve at 
the base of the skull and descends toward the superior pole of the 
thyroid along the internal carotid artery. At the level of the hyoid 
cornu, it divides into two branches. The larger internal branch has 
sensory function and enters the thyrohyoid membrane, where it 
innervates the larynx. The smaller external branch continues to 
travel along the lateral surface of the inferior pharyngeal constrictor 
muscle and usually descends anteriorly and medially along with 
the superior thyroid artery. Within 1 cm of the superior thyroid 
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artery's entrance into the thyroid capsule, the nerve usually takes a 
medial course and enters into the cricothyroid muscle. This is an 
extremely important relation because, during the performance of a 
thyroid lobectomy, the external branch is not usually visualized 
because it has already entered the inferior pharyngeal muscle 
fascia. This nerve is at risk of being severed or entrapped, 
however, if superior pole vessels are ligated at too great a distance 
above the superior pole of the thyroid. Damage to the external 
branch can result in a severe loss in quality of voice or voice 
strength. Although this may not be as clinically devastating as 
recurrent laryngeal nerve damage, it is extremely bothersome to 
patients whose occupation demands good voice quality. 
The cervical sympathetic chain 
This underlies the carotid sheath just medial to the vagus on the 
prevertebral fascia and is in close proximity to the inferior thyroid 
artery as it arches around medially. 
 
Parathyroid glands 
There are normally four parathyroid glands, the upper pair of which 
lies in close proximity to the dorsal aspect of the thyroid. They are 
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usually found just above and medial to where the recurrent 
laryngeal nerve crosses the inferior thyroid artery, frequently 
tucked round behind its branches. The lower parathyroid gland on 
each side is situated within a 2-cm radius of the lower pole of the 
thyroid, typically on its surface anterolaterally and at a level below 
and medial to where the recurrent laryngeal nerve crosses the 
inferior thyroid artery. 
Thyroid Histology 
Microscopically, the thyroid is divided into lobules that contain 20 
to 40 follicles. There are roughly 3 x 106 follicles in the adult male 
thyroid gland. The follicles are spherical and average 30 micromm 
in diameter. Each follicle is lined by cuboidal epithelial cells and 
contains a central store of colloid secreted from the epithelial cells 
under the influence of the pituitary hormone, TSH. The second 
group of thyroid secretory cells is the C cells or parafollicular cells, 
which contain and secrete the hormone calcitonin. They are found 
as individual cells or clumped in small groups in the interfollicular 
stroma and located in the upper poles of the thyroid lobes. 
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Thyroid Physiology 
Iodine Metabolism 
The average daily iodine requirement is 0.1 mg, which can be 
derived from foods such as fish, milk, and eggs, or as additives in 
bread or salt. In the stomach and jejunum, iodine is rapidly 
converted to iodide and absorbed into the bloodstream, from 
where it is distributed uniformly throughout the extracellular space. 
Iodide is actively transported into the thyroid follicular cells by an 
ATP-dependent process. In fact, the thyroid is the storage site of 
greater than 90% of the body's iodine content and accounts for 
one-third of the plasma iodine loss. The remaining plasma iodine is 
cleared via renal excretion. 
The hormones tri-iodothyronine (T3) and thyroxine (T4) (extracted 
by E.G. Kendall in 1916) are bound to thyroglobulin within the 
colloid. Synthesis within the thyroglobulin complex is controlled by 
several enzymes, in distinct steps: 
•trapping of inorganic iodide from the blood; 
•oxidation of iodide to iodine; 
•binding of iodine with tyrosine to form iodotyrosines; 
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•coupling of mono-iodotyrosines and di-iodotyrosines to form 13 
and T4 
•when hormones are required the complex is resorbed into the cell 
and thyroglobulin broken down; T3 and T4 are liberated and enter 
the blood. 
Thyroid Hormone Synthesis, Secretion, and Transport 
The synthesis of thyroid hormone consists of several steps. The 
first step, iodide trapping, involves active (ATP-dependent) 
transport of iodide across the basement membrane of the 
thyrocyte via an intrinsic membrane protein, the Na+/I– symporter 
(NIS). Thyroglobulin (Tg) is a large (660-kDa) glycoprotein, which 
is present in thyroid follicles and has four tyrosyl residues. The 
second step in thyroid hormone synthesis involves oxidation of 
iodide to iodine and iodination of tyrosine residues on Tg, to form 
monoiodotyrosines (MITs) and diiodotyrosines (DITs). Both 
processes are catalyzed by thyroid peroxidase. The recently 
identified protein pendrin is thought to mediate iodine efflux at the 
apical membrane.5 The third step leads to coupling of two DIT 
molecules to form tetraiodothyronine or thyroxine (T4), and one DIT 
molecule with one MIT molecule to form 3,5,3'-triiodothyronine (T3) 
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or reverse 3,3',5'-triiodothyronine (rT3). When stimulated by TSH, 
thyrocytes form pseudopodia, that encircle portions of cell 
membrane containing thyroglobulin, which, in turn, fuse with 
enzyme-containing lysosomes. In the fourth step, thyroglobulin is 
hydrolyzed to release free iodothyronines (T3 and T4) and mono- 
and diiodotyrosines. The latter are deiodinated in the fifth step to 
yield iodide, which is reused in the thyrocyte. 
In the euthyroid state, T4 is produced and released entirely by the 
thyroid gland, whereas only 20% of the total T3 is produced by the 
thyroid. Most of the T3 is produced by peripheral deiodination 
(removal of 5'-iodine from the outer ring) of T4 in the liver, muscles, 
kidney, and anterior pituitary, a reaction that is catalyzed by 5'-
monodeiodinase. Some T4 is converted to rT3, the metabolically 
inactive compound, by deiodination of the inner ring of T4. In 
conditions such as Graves' disease, toxic multinodular goiter, or a 
stimulated thyroid gland, the proportion of T3 released from the 
thyroid may be dramatically elevated. Thyroid hormones are 
transported in serum bound to carrier proteins such as thyroxine-
binding globulin (TBG), thyroxine-binding prealbumin (TBPA), and 
albumin. Only a small fraction (0.02%) of thyroid hormone (T3 and 
T4) is free (unbound) and is the physiologically active component. 
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T3 is the more potent of the two thyroid hormones, although its 
circulating plasma level is much lower than that of T4. T3 is less-
tightly bound to protein in the plasma than is T4, and so it enters 
tissues more readily. T3 is three to four times more active than T4 
per unit weight, with a half-life of about 1 day, compared to 
approximately 7 days for T4. 
The secretion of thyroid hormone is controlled by the 
hypothalamic–pituitary–thyroid axis. The hypothalamus produces a 
peptide, the thyrotropin-releasing hormone (TRH), which 
stimulates the pituitary to release TSH or thyrotropin. TRH reaches 
the pituitary via the portovenous circulation. TSH, a 28-kDa 
glycopeptide, mediates iodide trapping, secretion, and release of 
thyroid hormones, in addition to increasing the cellularity and 
vascularity of the thyroid gland. The TSH receptor belongs to a 
family of G-protein-coupled receptors that have seven 
transmembrane-spanning domains and utilize cAMP in the signal-
transduction pathway. TSH secretion by the anterior pituitary also 
is regulated via a negative feedback loop by T4 and T3. Because 
the pituitary has the ability to convert T4 to T3, the latter is thought 
to be more important in this feedback control. T3 also inhibits the 
release of TRH. 
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Calcitonin 
Calcitonin is a 32-amino acid polypeptide and is secreted by the C 
cells, which are parafollicular cells located superolaterally in each 
thyroid lobe. Calcitonin acts principally to inhibit bone resorption of 
calcium and thereby to lower peripheral serum calcium levels. 
Increased peripheral levels of serum calcium stimulate calcitonin 
secretion. Calcitonin secretion can be stimulated clinically by 
infusion of calcium, pentagastrin, and alcohol. 
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The specific action of calcitonin is on the surface receptors of 
osteoclasts. Calcitonin receptors have also been found in renal 
tubular epithelium and in lymphocytes. Calcitonin has a direct 
action on osteoclasts, which may or may not result in a marked 
decrease in calcium levels. In fact, patients with clinical calcitonin 
excess syndromes, such as medullary carcinoma of the thyroid 
(MCT), have little alteration in peripheral calcium metabolism. 
Basal or stimulated calcitonin levels are sensitive markers for 
primary or recurrent MCT. Whether calcitonin should be evaluated 
routinely for all thyroid masses in an attempt to discover the 
unusual sporadic medullary carcinoma is not universally agreed 
on. 
Thyroid Hormone Function 
Free thyroid hormone enters the cell membrane by diffusion or by 
specific carriers and is carried to the nuclear membrane by binding 
to specific proteins. T4 is deiodinated to T3 and enters the nucleus 
via active transport, where it binds to the thyroid hormone receptor. 
The T3 receptor is similar to the nuclear receptors for 
glucocorticoids, mineralocorticoids, estrogens, vitamin D, and 
retinoic acid. In humans, two types of T3 receptor genes are 
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located on chromosomes 3 and 17. Each gene product has a 
ligand-independent, aminoterminal domain; a ligand-binding, 
carboxyterminal domain; and centrally located DNA-binding 
regions. Binding of thyroid hormone leads to the transcription and 
translation of hormone-responsive specific genes. 
Thyroid hormones affect almost every system in the body. They 
are important for fetal brain development and skeletal maturation. 
T3 increases oxygen consumption, basal metabolic rate and heat 
production by stimulation of Na+/K+ ATPase in various tissues. It 
also has a positive inotropic and chronotropic effect on the heart 
by increasing transcription of the Ca2+ ATPase in the sarcoplasmic 
reticulum and increasing levels of beta-adrenergic receptors and 
concentration of G proteins. Myocardial receptors are decreased 
and actions of catecholamines are amplified. Thyroid hormones 
are responsible for maintaining the normal hypoxic and 
hypercapnic drive in the respiratory center of the brain. They also 
increase gastrointestinal motility, leading to diarrhea in 
hyperthyroidism and constipation in hypothyroidism. Thyroid 
hormones also increase bone and protein turnover and the speed 
of muscle contraction and relaxation. They also increase 
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glycogenolysis, hepatic gluconeogenesis, intestinal glucose 
absorption, and cholesterol synthesis and degradation. 
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Pathology  
The normal thyroid gland is impalpable. The term goiter (Latin, 
guttur = the throat) is used to describe generalised enlargement of 
the thyroid gland. A discrete swelling (nodule) in one lobe with no 
palpable abnormality elsewhere is termed an isolated (or solitary) 
swelling. Discrete swellings with evidence of abnormality 
elsewhere in the gland are termed dominant. 
Classification 
 Simple  
 Toxic   
 Neoplastic  
 Inflammatory  
 Infective  
 Others  
Simple goiter 
Aetiology 
Simple goiter may develop as a result of stimulation of the thyroid 
gland by TSH, either as a result of inappropriate secretion from a 
micro adenoma in the anterior pituitary (which is rare), or in 
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response to a chronically low level of circulating thyroid hormones. 
The most important factor in endemic goiter is dietary deficiency of 
iodine but defective hormone synthesis probably accounts for 
many sporadic goiters. TSH is not the only stimulus to thyroid 
follicular cell proliferation and other growth factors including 
immunoglobulins exert an influence. The heterogeneous structural 
and functional response in the thyroid resulting in characteristic 
nodularity may be due to the presence of clones of cells 
particularly sensitive to growth stimulation. 
Stages in goiter formation are:  
•Persistent growth stimulation causes diffuse hyperplasia; all 
lobules are composed of active follicles and iodine uptake is 
uniform. This is a diffuse hyperplastic goiter, which may persist for 
a long time but is reversible if stimulation ceases; 
•Later, as a result of fluctuating stimulation, a mixed pattern 
develops with areas of active lobules and areas of inactive lobules; 
•Active lobules become more vascular and hyperplastic until 
haemorrhage occurs, causing central necrosis and leaving only a 
surrounding rim of active follicles; 
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•Necrotic lobules coalesce to form nodules filled with either iodine-
free colloid or a mass of new but inactive follicles; 
•Continual repetition of this process results in a nodular goiter. 
Most nodules are inactive and active follicles are present only in 
the inter nodular tissue. 
Clinically discrete swellings 
Discrete thyroid swellings (thyroid nodules) are common and are 
present in 3—4 per cent of the adult population 
Some 15per cent of isolated swellings prove to be malignant, and 
an additional 30—40 per cent are follicular adenomas. The 
remainder are non-neoplastic largely consisting of areas of colloid 
degeneration, thyroiditis or cysts. 
Neoplasms of the thyroid 
Benign tumours 
Follicular adenomas present as clinically solitary nodules and the 
distinction between a follicular carcinoma and an adenoma can 
only be made by histological examination: in the adenoma there is 
no invasion of the capsule or of pericapsular blood vessels. 
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Malignant tumours 
The vast majority of primary growths is carcinomas. Dunhill 
classified them histologically as differentiated and undifferentiated: 
and the differentiated carcinomas are now subdivided into follicular 
and papillary. Secondary growths are rare but blood-borne 
metastases occur. Blood borne metastases more usually occur 
from primary carcinomas of breast, colon and kidney and from 
melanomas. 
Etiology of malignant thyroid tumours 
Differentiated thyroid carcinoma, particularly papillary, frequently 
follows accidental irradiation of the thyroid in childhood. The 
incidence of follicular carcinoma is high in endemic goitrous areas, 
possibly owing to TSH stimulation. Malignant lymphomas can 
present in a patient known to have autoimmune thyroiditis, so that 
the lymphocytic infiltration in the autoimmune process may be an 
etiological factor. Indeed, it is likely that all lymphomas of the 
thyroid arise in glands affected by such thyroiditis. 
Clinical features of thyroid neoplasms 
The annual incidence is about 3.7 per 100 000 of the population 
and the sex ratio is three females to one male. The mortality 
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should only be of the order of 2—3 per cent. The commonest 
presenting symptom is a thyroid swelling and a 5-year history is far 
from uncommon in differentiated growths. Enlarged cervical lymph 
nodes may be the presentation of papillary carcinoma. Recurrent 
laryngeal nerve paralysis may be a presenting feature of locally 
advanced disease. 
Papillary carcinoma 
Most papillary tumours contain a mixture of papillary and colloid-
filled follicles, and in some the follicular structure predominates. 
Nevertheless, if any papillary structure is present, the tumour will 
behave in a predictable fashion as a papillary carcinoma. 
Histologically the tumour shows papillary projections and 
characteristic pale, empty nuclei (Orphan Annie-eyed nuclei). 
Papillary carcinomas are very seldom encapsulated. Multiple foci 
may occur in the same lobe as the primary tumour or, less 
commonly, in both lobes. They may be due to lymphatic spread in 
the rich intrathyroidal lymph plexus, or to multicentric growth. 
Follicular carcinoma 
These appear to be macroscopically encapsulated but 
microscopically there is invasion of the capsule and of the vascular 
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spaces in the capsular region. Multiple foci are seldom seen and 
lymph node involvement is much less common than in papillary 
carcinoma. Blood-borne metastases are almost twice as common 
Undifferentiated (anaplastic) carcinoma 
This occurs mainly in elderly women and is much less often 
diagnosed now than in the past when many thyroid lymphomas 
were mistakenly classified histologically as anaplastic carcinomas. 
Local infiltration is an early feature of these tumours with spread by 
lymphatics and by the bloodstream. 
Medullary carcinoma 
These are tumours of the parafollicular (C)-cells derived from the 
neural crest and there is a characteristic amyloid stroma . High 
levels of serum calcitonin (>0.08 ng/ml) are produced by many 
medullarv tumours. 
Thyroiditis 
Chronic Iymphocytic (autoimmune) thyroiditis 
It commonly presents as a multinodular goiter. Features of chronic 
lymphocytic (focal) thyroiditis are commonly present on histological 
examination in association with other thyroid disease — notably 
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toxic goiter. Primary myxoedema without detectable thyroid 
enlargement repre-sents the end stage of the pathological 
process. 
Granulomatous thyroiditis (subacute thyroiditis —de 
Quervain’s thyroiditis)-This is due to a virus infection. In a typical 
subacute presentation there is pain in the neck, fever, malaise and 
a firm, irregular enlargement of one or both thyroid lobes. 
Riedel’s thyroiditis-This is very rare, accounting for 0.5per cent of 
goiters. Thyroid tissue is replaced by cellular fibrous tissue which 
infiltrates through the capsule into adjacent muscles, para tracheal 
connective tissue and the carotid sheaths. 
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Diagnostic aids 
Examination sequence 
  Inspect the neck from the front. 
  Look for a thyroid swelling while the patient swallows a sip 
of water. The thyroid (or a thyroglossal cyst) moves upwards 
on swallowing since it is enveloped in the pretracheal fascia, 
which is attached to the cricoid cartilage. 
  Ask the patient to sit with the neck muscles relaxed and 
stand behind the patient. 
  Place your hands gently on the front of the patient's neck 
with your index fingers just touching the goiter. 
 Note the size, shape and consistency of any goiter, and the 
presence or absence of a thrill. Measure any discrete 
nodules with calipers. 
  Listen with the diaphragm of your stethoscope for a thyroid 
bruit. 
 Look for any lymph nodes. 
Tests of Thyroid Function: A multitude of different tests are 
available to evaluate thyroid function. No single test is sufficient to 
assess thyroid function in all situations and the results must be 
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interpreted in the context of the patient's clinical condition. TSH is 
the only test necessary in most patients with thyroid nodules that 
clinically appear to be euthyroid. 
Serum TSH 
The tests for serum TSH (normal 0.5 to 5 mIU/mL) are based on 
the principle that monoclonal TSH antibodies are bound to a solid 
matrix and bind serum TSH. A second monoclonal antibody binds 
to a separate epitope on TSH and is labeled with radioisotope, 
enzyme or fluorescent tag. Therefore, the amount of serum TSH is 
proportional to the amount of bound secondary antibody 
(immunometric assay). Older radioimmunoassays for TSH were 
able to detect elevated TSH levels in hypothyroidism, but were not 
sensitive enough to detect suppressed levels of TSH characteristic 
of hyperthyroidism. Newer, second-generation, "sensitive" TSH 
assays can measure levels less than 0.1mIU/mL and third-
generation or "supersensitive or ultrasensitive" assays can detect 
TSH levels as low as 0.01mIU/mL. Serum TSH levels reflect the 
ability of the anterior pituitary to detect free T4 levels. There is an 
inverse relationship between the free T4 level and the logarithm of 
the TSH concentration—small changes in free T4 lead to a large 
36 
 
shift in TSH levels. Thus, the ultrasensitive TSH assay has 
become the most sensitive and specific test for the diagnosis of 
hyper- and hypothyroidism and for optimizing T4 replacement and 
suppressive therapy. 
Total T4 and Total T3 
Total T4 (reference range: 55 to 150 nmol/L) and T3 (reference 
range:1.5 to 3.5 nmol/L) levels are measured by radio-
immunoassay and measure both the free and bound components 
of the hormones. Total T4 levels reflect the output from the thyroid 
gland, whereas T3 levels in the non-stimulated thyroid gland are 
more indicative of peripheral thyroid hormone metabolism and are, 
therefore, not generally suitable as a general screening test. Total 
T4 levels are increased not only in hyperthyroid patients, but also in 
those patients with elevated thyroglobulin levels secondary to 
pregnancy, estrogen/progesterone use, or congenital diseases. 
Similarly, total T4 levels decrease in hypothyroidism and in patients 
with decreased thyroglobulin levels caused by anabolic steroid use 
and by protein-losing disorders such as nephrotic syndrome. 
Individuals with these latter disorders may be euthyroid if their free 
T4 levels are normal. Measurement of total T3 levels is important in 
37 
 
clinically hyperthyroid patients with normal T4 levels, who may 
have T3 thyrotoxicosis. As discussed previously, total T3 levels are 
often increased in early hypothyroidism. 
Free T4 and Free T3 
These radioimmunoassay-based tests are a sensitive and 
accurate measurement of biologically active thyroid hormone. Free 
T4 (reference range: 12 to 28 pmol/L) estimates are not performed 
as a routine screening tool in thyroid disease. Use of this test is 
confined to cases of early hyperthyroidism in which total T4 levels 
may be normal but free T4 levels are raised. In patients with end-
organ resistance to T4 (Refetoff syndrome), T4 levels are 
increased, but TSH levels usually are normal. Free T3 (reference 
range: 3 to 9 pmol/L) is most useful in confirming the diagnosis of 
early hyperthyroidism, in which levels of free T4 and free T3 rise 
before total T4 and T3. Free T4 levels may also be measured 
indirectly using the T3 resin-uptake test. If free T4 levels are 
increased, fewer hormone-binding sites are available for binding 
radiolabeled T3 that has been added to the patient's serum. 
Therefore, more T3 binds with an ion-exchange resin and the T3 
resin uptake is increased. 
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Evaluation of the Pituitary-Thyroid Feedback Loop 
Evaluation of serum TSH is an important screening test for the 
diagnosis of thyroid status. TSH is measured by an ultrasensitive 
radioimmunometric assay, and this has greatly improved clinical 
diagnosis. This is especially important in the delineation of 
hypothyroid from euthyroid states. Additionally, clinically euthyroid 
patients may have suppressed TSH values, demonstrating 
hyperthyroidism before it becomes clinically manifest. The 
sensitivity of the TSH assay is also less affected by nonthyroid 
disease processes and remains unaffected by changes in the 
thyroid hormone-binding proteins.  
More elaborate tests of the functional status of the hypothalamic-
pituitary axis may require the use of a TRH stimulation test. An 
intravenous dose of TRH is given, for which a normal response 
should be an elevation in TSH that peaks within 15 to 35 minutes. 
Pituitary insufficiency then demonstrates a subnormal response to 
TRH, whereas patients with primary hypothyroidism demonstrate 
an enhanced TSH release from the anterior pituitary. 
The use of the T3 suppression tests evaluates the autonomous 
function of the gland because T3 suppresses TSH release from the 
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pituitary. An 8-10 day course of T3 is administered, and a 
radioactive iodine uptake is then performed. The normal response 
should be a suppression of radioactive iodine uptake to less than 
50% of initial values. An autonomously hyperfunctioning thyroid 
gland demonstrates a lack of suppression of the radioactive iodine 
uptake. 
Thyroid Antibodies 
Thyroid antibodies include antithyroglobulin (anti-Tg), 
antimicrosomal or antithyroid peroxidase (anti-TPO) and thyroid-
stimulating immunoglobulin (TSI). Anti-Tg and anti-TPO antibody 
levels do not determine thyroid function; instead, they indicate the 
underlying disorder, usually an autoimmune thyroiditis. 
Approximately 80% of patients with Hashimoto's thyroiditis have 
elevated thyroid antibody levels, but levels may also be increased 
in patients with Graves' disease, multinodular goiter, and, 
occasionally, with thyroid neoplasms. 
Serum Thyroglobulin 
Thyroglobulin is not normally released into the circulation in large 
amounts, but increases dramatically in destructive processes of 
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the thyroid gland, such as thyroiditis or overactive states such as 
Graves' disease and toxic multinodular goiter. The most important 
use for serum thyroglobulin levels is in monitoring patients with 
differentiated thyroid cancer for recurrence, particularly after total 
thyroidectomy and radioactive iodine ablation. 
Erythrocyte sedimentation rate (ESR) 
The ESR is often raised (over 90 mm/h) in many patients with 
myxoedema and Hashimoto's thyroiditis, and is markedly elevated 
in de Quervain's thyroiditis. 
Calcitonin 
The parafollicular cells, or C cells, of the thyroid elaborate a 32-
amino acid polypeptide, calcitonin. The important physiologic 
consequence of calcitonin is to decrease peripheral levels of 
calcium. Malignancies that involve calcitonin excess include MCT, 
although the physiologic action of calcitonin does not appear to be 
manifest; hypocalcemia is not a problem in these patients. In 
patients with thyroid masses and in whom multiple endocrine 
neoplasia (MEN) Type 2 syndrome is suspected, a baseline 
calcitonin level can be drawn. If there is doubt about the diagnosis, 
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a pentagastrin- or calcium-stimulated calcitonin evaluation can be 
performed employing a 4- to 5-hour test. Additionally, calcitonin 
can be used as a screening test in families with MEN Type 2 
syndrome in documenting clinically inapparent disease. Use of 
calcitonin screening in patients with a thyroid mass, however, is 
most likely not cost-efficient. 
Fine-needle aspiration or aspiration biopsy cytology 
This technique, promoted by the Karolinska Institute in Sweden for 
over 40 years, has now gained acceptance as the procedure of 
choice in evaluating thyroid nodules, having replaced radionuclide 
and ultrasonographic scanning. A 25G disposable needle on a 10-
ml syringe enables cells to be aspirated from any suspicious area 
of the thyroid. 
       Though fine-needle aspiration cytology is the preferred 
investigation of choice in patients with thyroid nodules it does have 
some limitations in the diagnosis of follicular or Hurthle-cell 
neoplasms. It is unable to demonstrate whether capsular or 
vascular invasion is present, the criteria needed to establish 
malignancy. Thus, when follicular cells are demonstrated on fine-
needle aspiration from a thyroid nodule, 20 per cent will be 
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malignant and 80 per cent benign; thyroid lobectomy to obtain 
definitive histological diagnosis is recommended in these patients. 
The needle technique is also less reliable in patients who have had 
irradiation to the head and neck or have a family history of thyroid 
cancer, as many of these patients have multifocal lesions. 
Thyroid Imaging 
Radionuclide Imaging 
Both iodine-123 (123I) and iodine-131 (131I) are used to image the 
thyroid gland. The former emits low-dose radiation, has a half-life 
of 12 to 14 hours, and is used to image lingual thyroids or goiters. 
In contrast, 131I use leads to higher-dose radiation exposure and 
has a half-life of 8 to 10 days. Therefore, this isotope is used to 
screen and treat patients with differentiated thyroid cancers for 
metastatic disease. The images provide information not only about 
the size and shape of the gland, but also the distribution of 
functional activity. Areas that trap less radioactivity than the 
surrounding gland are termed "cold", whereas areas that 
demonstrate increased activity are termed "hot." The risk of 
malignancy is higher in "cold" lesions (15 to 20%) than in "hot" or 
"warm" lesions (<5%). Technetium-99m (99mTc) pertechnetate is 
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taken up by the thyroid gland and also used for thyroid evaluation. 
This isotope is taken up by the mitochondria, but is not organified. 
It also has the advantage of having a shorter half-life and 
minimizes radiation exposure. It is particularly sensitive for nodal 
metastases. More recently, 18 F-fluorodeoxyglucose positron 
emission tomography (FDG PET) has been used to screen for 
metastases in patients with thyroid cancer, in whom other imaging 
studies are negative. However, this technique is expensive and not 
widely available. 
 
Ultrasound 
Ultrasound is an excellent, noninvasive and portable imaging 
method for studying the thyroid gland, and it has the added 
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advantage of no radiation exposure. It is helpful in the evaluation 
of thyroid nodules, distinguishing solid from cystic ones, and 
providing information about size and multicentricity. Ultrasound 
also can be used to assess for cervical lymphadenopathy  and to 
guide fine-needle aspiration (FNA) biopsy. However, it cannot be 
used to image thyroid tissue outside the neck (e.g., to assess the 
extent of a substernal goiter). 
CT/MRI Scan 
These studies provide excellent imaging of the thyroid gland and 
adjacent nodes, and are particularly useful in evaluating the extent 
of large, fixed or substernal goiters and their relationship to the 
airway and vascular structures. Noncontrast CT scans should be 
obtained in patients who are likely to require subsequent 
radioactive iodine therapy. 
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Indications for surgery 
Non-toxic goiter 
Diffuse non-toxic goiter 
• If there is no response by giving thyroxine, thyroidectomy 
may be indicated on cosmetic grounds. 
Multinodular non-toxic goiter 
• Cosmetic disfigurement, pressure symptoms, and 
discomfort. 
Solitary nodular non-toxic goiter 
Thyrotoxicosis 
• Large toxic multinodular goiter/Plummer's disease 
• Large diffuse toxic goiter (Graves' disease) 
• Toxic solitary nodular goiter/toxic adenoma/autonomous ‘hot 
nodule' 
Thyroid cyst 
Carcinoma of the thyroid 
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Specific thyroid surgical procedures 
Hemi thyroidectomy 
Subtotal thyroidectomy 
Total  thyroidectomy 
SURGICAL APPROACHES TO THE THYROID GLAND  
Cervical Approach 
A transverse incision is made about two fingerbreadths above the 
clavicular heads. The skin incision should be carried through 
subcutaneous fat and the platysmal muscle and superior and 
inferior flaps dissected medially beneath the platysmal layer. At 
this layer, anterior jugular veins are identified, and any of those 
crossing or running along the midline can be divided. The midline 
raphe should then be identified between sternohyoid muscles, and 
this raphe should be divided in a bloodless plane from the thyroid 
cartilage superiorly to the sternal notch inferiorly. As one enters the 
plane immediately beneath the sternohyoid muscles, one 
encounters the isthmus of the thyroid in the midline and each of 
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the lobes laterally. Above and below the isthmus are the 
cartilaginous rings of the trachea. Blunt finger dissection can 
separate the sternohyoid muscle from the thyroid capsule medially 
and identify the sternothyroid muscles in a deep and lateral 
position. The sternothyroid muscles do not meet in the midline and 
must be separated off of the thyroid capsule to gain lateral 
exposure of the thyroid. Exposure of lateral structures is enhanced 
by placing medial traction on the thyroid lobes on either side. Care 
must be used to divide the middle thyroid vein before it is placed 
on excessive traction by this maneuver. 
After the superior pole vessels are carefully dissected and 
identified, they can be double-ligated adjacent to their entrance 
into the thyroid lobe. After the superior thyroid vessels and middle 
thyroid veins have been divided, continued medial retraction of the 
thyroid lobe allows the posterior aspect of the thyroid lobe to be 
visualized. It is in this area that the superior parathyroids are 
usually found lying within small deposits of fat within the thyroid 
sheath. 
Further mobilization of the thyroid lobe allows exposure of the 
tracheo-esophageal groove and the recurrent laryngeal nerve. 
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Minimal dissection of the lower vessels entering the thyroid should 
be undertaken, and no division should be done until the recurrent 
laryngeal nerve is seen and positively identified. 
After the recurrent laryngeal nerve is seen, the inferior vessels 
may be divided while the course of the recurrent laryngeal nerve is 
directly visualized. Continued medial traction of the lobe then 
identifies the cephalad course of the nerve to where it disappears 
under the ligament of Berry or into its final destination, the caudal 
border of the cricothyroid muscle. The ligament of Berry is in a 
position just anterior and slightly medial to the nerve's entrance 
underneath the cricothyroid muscle, and this structure, with a small 
rim of thyroid tissue, can be ligated using 3-0 silk suture. 
A total thyroidectomy involves division of all thyroid tissue between 
the entrances of the recurrent laryngeal nerves bilaterally by the 
ligament of Berry, resulting in complete removal of virtually all 
visible thyroid tissue bilaterally. A near-total thyroidectomy should 
involve complete dissection on one side while leaving a remnant of 
thyroid tissue laterally on the contralateral side, which should 
incorporate the parathyroids. A subtotal thyroidectomy leaves a rim 
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of thyroid tissue bilaterally, ensuring parathyroid viability and 
avoiding entrance of the recurrent laryngeal nerves into the larynx. 
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MATERIALS AND METHODS 
Design: 
A single institution study done during the period from July 2007 to 
October 2009 in the Department of Surgery, K.A.P.V.Government  
Medical College; A.G.M.GH, Trichy. All the patients who 
underwent thyroid surgeries were selected for the study.   
Setting: 
 Tertiary academic referral centre. 
Patient: 
Eighty seven patients who underwent thyroid surgeries for various 
thyroid disorders. 
 Selection  of patients: 
A patient with 
¾ Colloid goiter 
¾ Non toxic non malignant multinodular goiter 
¾ Solitary nodule 
¾ Carcinoma thyroid 
¾ Thyrotoxic  patient ,toxicity under control 
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RESULTS: 
This is a study of eighty seven patients during the period from July 
2007 to October 2009 in the Department of Surgery, 
K.A.P.V.Government Medical College; A.G.M.GH, TRICHY who 
underwent thyroid surgeries. 
PATIENTS: 
Of the eighty seven patients who underwent thyroid surgeries, 
eighty two were female and five were male, with a striking female 
preponderance. 
AGE: 
The average age of the patient is 36.65 years 
The average age of female patient is 36.24 years 
The average age of male patient is 43.2 years 
The minimum age is 7 years 
The maximum age is 70 years 
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Age presentation in our study is as follows: 
 
AGE IN 
YEARS 
FEMALE MALE TOTAL
<10 0 1 1 
11-20 1 0 1 
21-30 29 O 29 
31-40 31 2 33 
41-50 14 0 14 
51-60 6 0 6 
61-70 1 2 3 
TOTAL 82 5 87 
 
PRESENTATION: 
        The common symptom was swelling. Some had pain. Some 
had mild pressure effects. One secondary toxicosis patient had her 
symptom under control due to medications. 
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         No patient presented with neck nodes or secondary 
metastasis. 
 
 
The clinical presentations are as follows: 
Type  Goiter  Solitary 
nodule 
Carcinoma MNG Total 
No  19 45 5 18 87 
 
  
The final pathological diagnosis is: 
Type  Goiter  Adenoma Carcinoma MNG Thyroiditis  Total  
No  29 43 5 3 7 87 
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The FNAC results are as follows: 
FNAC Goiter  Nodule  Cyst Follicular 
neoplasm
 
Papillary
CA 
Thyroiditis Hyper-
plastic 
goitre 
Atypical 
adenoma 
Total 
No  30 39 1 8 4 3 1 1 87 
% 35 45 1 9 5 3 1 1 100
 
 
The biopsy results are as follows: 
Biopsy  MNG Adenoma  Goiter thyroiditis Follicular 
CA 
Papillary 
CA 
Medullary 
CA 
Total 
No  3 43 29 7 0 4 1 87 
% 5 50 34 8 0 4 1 100
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Cytodiagnosis  
Cytodiagnoses can be divided into these categories : benign (negative), 
suspicious (indeterminate), malignant (positive) 
Patients with a "benign" cytodiagnosis do not have malignancy and may 
have a normal thyroid, a colloid nodule, lymphocytic thyroiditis, subacute 
thyroiditis, or other benign conditions.   
Patients with a suspicious (indeterminate) cytodiagnosis have specimens 
showing hypercellularity and a pattern suggestive of follicular- or Hurthle-
cell neoplasms or atypical features suggestive of, but not diagnostic for, 
malignancy  
Patients with a malignant cytodiagnosis have cytologic findings indicating 
the presence of malignant cells consistent with primary or metastatic 
thyroid carcinoma. 
As per the  above criteria, our study shows: 
TYPE NO PERCENTAGE 
BENIGN 74 85 
MALIGNANT 4 5 
SUSPICIOUS 9 10 
TOTAL 87 100 
The 9 patients in suspicious category include 7 follicular neoplasm; 1 
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atypical adenoma; 1 hyperplastic goiter. 
Yield of cancer: 
               Defined as the ratio of the total number of patients with 
carcinoma to the total number of cases operated. 
 
False negative diagnosis: 
        Defined as percentage of patients with benign cytologic findings who 
are confirmed to have malignant lesions of thyroid. 
False positive diagnosis: 
         Defined as percentage of patients with malignant fine needle 
aspirates who are found to have benign lesions at surgery. 
Sensitivity=true positive 
                  Truepos+falseneg 
Specificity=true  negative 
                 Trueneg+falsepos 
Sensitivity & specificity results depend on the suspicious category. If 
suspicious lesions are positive, then sensitivity increases & specificity 
decreases and vice versa. 
Our study shows: 
 One patient with papillary CA on FNAC had follicular lesion as her 
biopsy report- one false positive 
 One patient with atypical adenoma had papillary CA as her biopsy 
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report- one false negative 
Our study values are: 
DIAGNOSIS TRUE 
POSITIVE 
FALSE 
POSITIVE 
FALSE 
NEGATIVE 
TRUE 
NEGATIVE 
NO 4 1 1 81 
 
Applying these values , the results are: 
Sensitivity : 80% 
Specificity : 98.78% 
False negative%: 20% 
False positive%: 1.2%  
YIELD:5.7% 
The types of surgeries are as follows: 
Hemi thyroidectomy 
Subtotal thyroidectomy 
Total thyroidectomy 
Maximum number of patients underwent hemithyroidectomy. 
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The values of these procedures are as follows: 
Type  N0 
Hemi thyroidectomy 56 
Subtotal thyroidectomy 26 
Total thyroidectomy 5 
Total 87 
 
PERCENTAGE OF MALIGNANCY IN SUSPICIOUS LESIONS: 
Type  Number  Percentage  
Benign  8 89 
Malignant  1 11 
Total  9 100 
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Management guidelines for patients with thyroid nodules and 
differentiated thyroid cancer recommend FNAC as the procedure 
of choice in the evaluation of thyroid nodules. 
SYLVIA L.ASA reported that the follicular lesion which belongs to 
the suspicious category needs clinico pathological correlation for 
management. 
JOHN BOEY et al reported a sensitivity rate of 92%. 
M. Regina Castro, MD, and Hossein Gharib, MD “Continuing 
Controversies in the Management of Thyroid Nodules” Ann Intern 
Med. 2005;142:926-931 reported that Management of patients with 
nodules “suspicious for follicular neoplasm” is difficult, since only 
15% to 20% of such lesions have been shown to be malignant. 
Our study result is 11%. 
YS Cheung,et al  has high specificity and positive predictive values 
for thyroid cancer. He gives comparison of certain series: 
 
 
Discussion :   
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series No  malig- 
nant% 
Susp-
icious
FP
% 
FN
% 
Sens- 
itivity%
Spec- 
ificity% 
PPV 
% 
NPV
% 
Gharib 
etal1993 
3144 32 10 3 5 83 92 83 92 
Cheung  
etal1997 
662 25 22 8 10 65 98 92 95 
Ogawa  
etal2001 
226 67 16 1 13 76 73 85 60 
Sclabas  
etal2003 
240 43 42 4 4 71 98 96 82 
Morgan  
etal2003 
253 93 29 26 46 55 74 70 67 
Our 
study 
87 5 9 1 20 80 99 80 99 
 
On comparing the clinical presentation with final diagnosis, there 
are major differences. Although the carcinoma cases have high 
specificity, the benign lesions show high variability. 
     19 cases presented with MNG have their final diagnosis as 
follows: 7 adenoma; 6 colloid goiter; 3 thyroiditis; and only 2 MNG 
       Other variations noted are 3 goiter cases have their final 
diagnosis as adenoma. 6 adenoma cases have their final 
diagnosis as goiter. 
       3 thyroiditis case  have their final diagnosis as goiter. 
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CONCLUSION: 
          The clinical presentation of benign thyroid swellings have 
varied benign pathological diagnosis.  
         The commonest presentation is solitary nodule and the 
commonest pathological finding is adenoma. 
         Of the malignant pathological findings, no follicular 
carcinoma is detected and the predominant carcinoma is papillary 
carcinoma. 
           FNAC in our study has high specificity. Hence malignant 
lesions are diagnosed fairly accurately.  
                      However, its sensitivity is relatively low. 
Interpretation of negative result has to be made with caution to 
reduce the false negative rate.  
                      Hence Fine-needle aspiration biopsy is safe, 
accurate, and cost-effective. The procedure has a central role in 
the management of thyroid nodules and should be used as the 
initial diagnostic test. 
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